IRONWOOD PHARMACEUTICALS INC cotiza a 3.57 USD y tiene una capitalización bursátil de $589M. En los últimos 12 meses ha facturado $389M con un margen de flujo de caja libre del 42.9%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It sells linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritabl…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $0.31 | $0.24 | $-0.01 |
| Estimado | $0.31 | $0.28 | $0.24 | $0.01 |
| Sorpresa | — | +10.7% | +0.0% | -200.0% |
| Métrica | IRWD | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | 33.3% | -38.6% | +71.9% |
| Net Margin | 8.1% | -33.6% | +41.7% |
| FCF Margin | 42.9% | -13.9% | +56.8% |
| ROE | — | -40.4% | — |
| ROA | 6.0% | -32.0% | +38.1% |
| Current Ratio | 1.13 | 2.84 | -1.71 |
| Debt / Equity | — | 0.28 | — |